Finch Therapeutics Group Statistics
Total Valuation
FNCH has a market cap or net worth of $3.21 million. The enterprise value is $12.01 million.
| Market Cap | 3.21M |
| Enterprise Value | 12.01M |
Important Dates
The last earnings date was Friday, May 10, 2024, before market open.
| Earnings Date | May 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
FNCH has 1.61 million shares outstanding. The number of shares has increased by 0.18% in one year.
| Shares Outstanding | 1.61M |
| Shares Change (YoY) | +0.18% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 53.48% |
| Owned by Institutions (%) | 11.35% |
| Float | 792,862 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.17 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.05, with a Debt / Equity ratio of 1.55.
| Current Ratio | 6.05 |
| Quick Ratio | n/a |
| Debt / Equity | 1.55 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 12.43 |
Financial Efficiency
Return on equity (ROE) is -68.10% and return on invested capital (ROIC) is -47.89%.
| Return on Equity (ROE) | -68.10% |
| Return on Assets (ROA) | -28.10% |
| Return on Capital (ROIC) | -47.89% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$16.28M |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.98% in the last 52 weeks. The beta is 0.46, so FNCH's price volatility has been lower than the market average.
| Beta (1Y) | 0.46 |
| 52-Week Price Change | -80.98% |
| 50-Day Moving Average | 2.41 |
| 200-Day Moving Average | 3.79 |
| Relative Strength Index (RSI) | 42.23 |
| Average Volume (30 Days) | 52,908 |
Short Selling Information
The latest short interest is 26,349, so 1.64% of the outstanding shares have been sold short.
| Short Interest | 26,349 |
| Short Previous Month | 10,600 |
| Short % of Shares Out | 1.64% |
| Short % of Float | 3.32% |
| Short Ratio (days to cover) | 0.28 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -23.28M |
| Pretax Income | -16.28M |
| Net Income | -16.28M |
| EBITDA | -14.28M |
| EBIT | -17.71M |
| Earnings Per Share (EPS) | -$10.14 |
Balance Sheet
The company has $20.76 million in cash and $29.56 million in debt, giving a net cash position of -$8.80 million or -$5.48 per share.
| Cash & Cash Equivalents | 20.76M |
| Total Debt | 29.56M |
| Net Cash | -8.80M |
| Net Cash Per Share | -$5.48 |
| Equity / Book Value | 19.04M |
| Book Value Per Share | 11.86 |
| Working Capital | 17.68M |
Cash Flow
In the last 12 months, operating cash flow was -$22.49 million and capital expenditures $1.34 million, giving a free cash flow of -$21.15 million.
| Operating Cash Flow | -22.49M |
| Capital Expenditures | 1.34M |
| Free Cash Flow | -21.15M |
| FCF Per Share | -$13.17 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FNCH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.18% |
| Shareholder Yield | -0.18% |
| Earnings Yield | -507.02% |
| FCF Yield | -658.41% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 12, 2023. It was a reverse split with a ratio of 1:30.
| Last Split Date | Jun 12, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |